Also categorized in BoardNews:
Getting Gen-Y on Boards (of Directors)
x hide permanently

Valeant CEO Papa says Drugmaker has 'Turnaround Opportunity of a Lifetime'

(Bloomberg) -- Valeant Pharmaceuticals International Inc. became a household name with its historic rise and fall. Reviving the drugmaker is proving a unique challenge. “This is a turnaround opportunity of a lifetime,” Chief Executive Officer Joseph Papa, who took over in May 2016, said during a presentation Wednesday at the J.P. Morgan Healthcare Conference in San Francisco...

Mentions: Conference Valeant Pharmaceuticals stake